Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 97.42% is 327% above its 5-year average of -42.90%, near the high end of its 5-year range (-26070.87%–100.00%).
13.62% above its 12-month average of 85.74%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 83.92%.
GROSS MARGIN
97.42%
GROSS MARGIN AVG TTM
85.74%
GROSS MARGIN AVG 3Y
98.49%
GROSS MARGIN AVG 5Y
-42.90%
GROSS MARGIN AVG 10Y
-3778.11%
GROSS MARGIN AVG 15Y
-472.56%
GROSS MARGIN AVG 20Y
-292.49%
CURRENT VS TTM AVG
+13.62%
CURRENT VS 3Y AVG
-1.08%
CURRENT VS 5Y AVG
+327.06%
CURRENT VS 10Y AVG
+102.58%
CURRENT VS 15Y AVG
+120.62%
CURRENT VS 20Y AVG
+133.31%
SECTOR MEDIAN · HEALTHCARE
41.76%
median of 627 covered companies
CURRENT VS SECTOR MEDIAN
+133.29%
vs the sector median at left
Geron Corporation
Market Cap
$769.83M
Gross Margin
97.42%
TTM Avg
85.74%
3Y Avg
98.49%
5Y Avg
-42.90%
Market Cap
$770.68M
Gross Margin
98.85%
TTM Avg
98.73%
3Y Avg
-10570.46%
5Y Avg
-10093.61%
Market Cap
$768.31M
Gross Margin
65.99%
TTM Avg
63.07%
3Y Avg
62.20%
5Y Avg
62.16%
Market Cap
$785.71M
Gross Margin
10.37%
TTM Avg
19.20%
3Y Avg
18.44%
5Y Avg
17.81%
Market Cap
$785.44M
Gross Margin
94.30%
TTM Avg
95.84%
3Y Avg
95.72%
5Y Avg
72.44%
Market Cap
$750.73M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$760.77M
Gross Margin
40.44%
TTM Avg
20.22%
3Y Avg
20.22%
5Y Avg
20.22%
Market Cap
$748.60M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
25.00%
5Y Avg
50.00%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Geron Corporation (GERN) | $769.83M | 97.42% | 85.74% | 98.49% | -42.90% |
| Lexicon Pharmaceuticals, Inc. (LXRX)vs › | $770.68M | 98.85% | 98.73% | -10570.46% | -10093.61% |
| Mesa Laboratories, Inc. (MLAB)vs › | $768.31M | 65.99% | 63.07% | 62.20% | 62.16% |
| AdaptHealth Corp. (AHCO)vs › | $785.71M | 10.37% | 19.20% | 18.44% | 17.81% |
| Gyre Therapeutics, Inc. (GYRE)vs › | $785.44M | 94.30% | 95.84% | 95.72% | 72.44% |
| Design Therapeutics, Inc. (DSGN)vs › | $750.73M | 0.00% | 0.00% | 0.00% | 0.00% |
| Attovia Therapeutics, Inc. (ATTO)vs › | $760.77M | 40.44% | 20.22% | 20.22% | 20.22% |
| Candel Therapeutics, Inc. (CADL)vs › | $748.60M | 0.00% | 0.00% | 25.00% | 50.00% |
| InMode Ltd. (INMD)vs › | $805.59M | 76.52% | 79.43% | 81.57% | 82.72% |
| Apnimed, Inc. (APMD)vs › | $805.62M | N/A | N/A | N/A | N/A |
Gross Margin
97.4%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 83.92% |
| 2026-03-31 | 96.74% |
| 2025-12-31 | 97.28% |
| 2025-09-30 | 53.18% |
| 2025-06-30 | 97.57% |
| 2025-03-31 | 96.95% |
| 2024-12-31 | 98.35% |
| 2024-09-30 | 98.39% |
| 2024-06-30 | 98.07% |
| 2024-03-31 | 100.00% |
| 2023-12-31 | 100.00% |
| 2023-09-30 | 100.00% |
| 2023-06-30 | 100.00% |
| 2023-03-31 | 100.00% |
| 2022-12-31 | -26070.87% |
| 2022-09-30 | -8183.84% |
| 2022-06-30 | 100.00% |
| 2022-03-31 | -17866.67% |
| 2021-12-31 | -2106.92% |
| 2021-09-30 | -16897.25% |
| 2021-06-30 | -20401.87% |
| 2021-03-31 | -15310.95% |
| 2020-12-31 | -29484.00% |
| 2020-09-30 | 100.00% |
| 2020-06-30 | -25120.93% |
| 2020-03-31 | -12653.85% |
| 2019-12-31 | -14007.02% |
| 2019-09-30 | -8380.15% |
| 2019-06-30 | -9933.66% |
| 2019-03-31 | -7077.19% |
| 2018-12-31 | -985.07% |
| 2018-09-30 | -1083.64% |
| 2018-06-30 | -1075.00% |
| 2018-03-31 | -493.40% |
| 2017-12-31 | -931.41% |
| 2017-09-30 | -1155.21% |
| 2017-06-30 | -954.60% |
| 2017-03-31 | -381.56% |
| 2016-12-31 | -3600.00% |
| 2016-09-30 | 29.95% |
| 2016-06-30 | -1639.34% |
| 2016-03-31 | -429.91% |
| 2015-12-31 | -1140.91% |
| 2015-09-30 | 92.69% |
| 2015-06-30 | -879.28% |
| 2015-03-31 | -235.38% |
| 2014-12-31 | -669.66% |
| 2014-09-30 | -1988.13% |
| 2014-06-30 | -564.52% |
| 2014-03-31 | -305.91% |
| 2013-12-31 | -913.33% |
| 2013-09-30 | -1298.34% |
| 2013-06-30 | -1144.64% |
| 2013-03-31 | -261.83% |
| 2012-12-31 | -687.81% |
| 2012-09-30 | 100.00% |
| 2012-06-30 | 100.00% |
| 2012-03-31 | 100.00% |
| 2011-12-31 | 100.00% |
| 2011-09-30 | 100.00% |
| 2011-06-30 | 100.00% |
| 2011-03-31 | 100.00% |
| 2010-12-31 | 100.00% |
| 2010-09-30 | -2414.29% |
| 2010-06-30 | 100.00% |
| 2010-03-31 | 100.00% |
| 2009-12-31 | 100.00% |
| 2009-09-30 | 100.00% |
| 2009-06-30 | 100.00% |
| 2009-03-31 | 100.00% |
| 2008-12-31 | 100.00% |
| 2008-09-30 | 100.00% |
| 2008-06-30 | 100.00% |
| 2008-03-31 | 100.00% |
| 2007-12-31 | 100.00% |
| 2007-09-30 | 100.00% |
| 2007-06-30 | 100.00% |
| 2007-03-31 | 100.00% |
| 2006-12-31 | 100.00% |
| 2006-09-30 | 100.00% |
| 2006-06-30 | 100.00% |
| 2006-03-31 | 100.00% |
| 2005-12-31 | 100.00% |
| 2005-09-30 | 100.00% |
| 2005-06-30 | 100.00% |
| 2005-03-31 | 100.00% |
| 2004-12-31 | 100.00% |
| 2004-09-30 | 100.00% |
| 2004-06-30 | 100.00% |
| 2004-03-31 | 100.00% |
| 2003-12-31 | 100.00% |
| 2003-09-30 | 100.00% |
| 2003-06-30 | 100.00% |
| 2003-03-31 | 100.00% |
| 2002-12-31 | 100.00% |
| 2002-09-30 | 100.00% |
